114
S. Mehta et al.
irradiation and give the desired products in high yields and excellent
purities. Further structural identification was achieved by elemental
and spectral data. Further, it is observed that some of the screened
compounds were highly active against the test microorganism.
REFERENCES
[1] S. Crosignani, D. Launay, B. Linclau, and M. Bradley, Mol. Diversity, 7, 203 (2003).
[2] S. Galema, Chem. Soc. Rev., 26, 233 (1997).
[3] S. Caddick, Tetrahedron, 51, 373 (1995).
[4] M. Koparir (Kopanr), A. Cetin, and A. Cansiz, Molecules, 10, 475 (2005).
[5] M. Metwally, H. Etman, E. Keshk, A. Fekry, Phosphorus, Sulfur, and Silicon, and
the Related Elements, 181, 1039 (2006).
[6] N. Srinivasan, and A. Ganesan, Chem. Commun., 916 (2003).
[7] M. E. Theoclitou, and L. A. Robinson, Tetrahedron Lett., 43, 3907 (2002).
[8] a) Z. Zhao, W. H. Leister, K. A. Strauss, D. D. Wisnoski, and C. W. Lindsley, Tetrahe-
dron Lett., 44, 1123 (2003); b) C. W. Lindsley, D. D. Wisnoski, Y. Wang, W. H. Leister,
and Z. Zhao, Tetrahedron Lett., 44, 4495 (2003).
[9] a) N. Mont, J. Teixido´, J. I. Borell, and C. O. Kappe, Tetrahedron Lett., 44, 5385
(2003); b) N. Mont, J. Teixido´, J. I. Borell, and C. O. Kappe, Mol. Diversity, 7, 153
(2003).
¨
[10] L. Ohberg, and J. Westman, Synlett, 1296 (2001).
[11] A. Mobinikhaledi, and N. Foroughifar, Phosphorus, Sulfur, and Silicon, and the
Related Elements, 181, 405 (2006).
[12] a) A. Varvaresou, A. Tsantili-Kakoulidou, T. Siatra-Papastasikoudi, and E. Tiligada,
Arzneimittelforschung, 50, 48 (2000); b) A. Varvaresou, T. Siatra-Papastsikoudi, A.
Tsontinis, A. Tsantili-Kakoulidou, and A. Vamvakides, Farmaco, 53, 320 (1998).
[13] Heravi Majid, Nami Navabeh, Oskooie Hossein, Heknat Shoar, and Rahim, Phos-
phorus, Sulfur, and Silicon, and the Related Elements, 181, 87 (2006).
[14] M. E. Azab, G. A. El-Hag Ali, and A. H. Abd El-Waheb, Acta Pharm, 53, 213 (2003).
[15] G. Amr Acl, H. H. Sayed, and M. M. Abdulla, Arch Pharm (Weinheim), 338, 433
(2005).
[16] L. Labanauskas, V. Kalcas, E. Udrenaite, P. Gaidelis, A. Brukstus, and V. Dauksas,
Pharmazie, 56, 617 (2001).
[17] M. Wujec, M. Pitucha, M. Dobosz, U. Kosikowska, and A. Malm, Acta Pharm, 54,
251 (2004).
[18] M. Gokce, B. Cakir, K. Erol, and M. F. Sahin, Arch. Pharm., 334, 279 (2001).
[19] Y. Tanabe, H. Yamamoto, M. Murakami, K. Yanagi, Y. Kubota, H. Okumura, Y.
Sanemitsu, and G. Suzukamo, J. Chem. Soc. Perkin Trans I, 7, 935 (1995).
[20] A. Rao, A. Carbone, A. Chimirri, E. De Clercq, A. M. Monforte, P. Monforte, C.
Pannecouque, and M. Zappala´, Il Farmaco, 58, 115 (2003).
[21] A. Rao, J. Balzarini, A. Carbone, A. Chimirri, E. De Clercq, A. M. Monforte, P.
Monforte, C. Pannecouque, and M. Zappala´, Il Farmaco, 59, 33 (2004).
[22] G. J. Collee, G. A. Fraser, P. B. Mamion, and A. Suninous,Practical Medical Micro-
biology 14th Ed. Vol. 11, Churchill Luingstone, Eclinbury, 163 (1996).